Brought to you by 
Boston Scientific buys Sadra Medical for up to $386mm in cash
02 Jun 2011
Executive Summary
Boston Scientific Corp. has agreed to buy the 86% of closely held Sadra Medical Inc. (minimally invasive devices for aortic valve disease) that it doesn't already own for $193mm in cash, plus up to $193mm in earn-outs through 2016. The additional funds will be released when Sadra's Lotus valve system receives US approval and begins generating revenue.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Acquisition
- Includes Earnout
- Partial Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Boston Scientific buys Sadra Medical for up to $386mm in cash
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice